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Background. The development of active tuberculosis disease has been shown to be 
multifactorial. Interactions between host and bacterial genotype may inﬂuence disease 
outcome, with some studies indicating the adaptation of M. tuberculosis strains to 
speciﬁc human populations. Here we investigate the role of the human leukocyte antigen 
(HLA) class I genes in this biological process. 
Methods. Three hundred patients with tuberculosis from South Africa were typed for 
their HLA class I alleles by direct sequencing. Mycobacterium tuberculosis genotype 
classiﬁcation was done by IS6110 restriction fragment length polymorphism genotyping 
and spoligotyping. 
Results. We showed that Beijing strain occurred more frequently in individuals with 
multiple disease episodes (P < .001) with the HLA-B27 allele lowering the odds of having 
an additional episode (odds ratio, 0.21; P = .006). Associations were also identiﬁed for 
speciﬁc HLA types and disease caused by the Beijing, LAM, LCC, and Quebec strains. 
HLA types were also associated with disease caused by strains from the Euro-American or 
East Asian lineages, and the frequencies of these alleles in their sympatric human 
populations identiﬁed potential coevolutionary events between host and pathogen. 
Conclusions. This is the ﬁrst report of the association of human HLA types and M. 
tuberculosis strain genotype, highlighting that both host and pathogen genetics need to 
be taken into consideration when studying tuberculosis disease development. 
 
The human leukocyte antigen (HLA) class I molecules are involved in various biological 
processes and play an essential role in immunity [1]. These molecules act as multisite 
receptors; including peptides for antigen presentation, αβ T-cell receptors, and CD8 for 
cytotoxic T-cell response stimulation. The HLAs represent an unsurpassed example of 
polymorphism with thousands of SNPs identiﬁed to date [2]. This extreme diversity is 
believed to have occurred by selection events, allowing for the identiﬁcation of peptide 
antigens from various pathogens and stimulation of an effective immune response by 
upregulation of the Th1 pathway [3]. HLA data for various populations demonstrate 
signiﬁcant differences in allele frequencies between different geographical populations, 
with some HLA alleles completely absent from certain populations [4, 5]. The HLA genes 
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were the ﬁrst to be associated with susceptibility to tuberculosis, and many different HLA 
alleles have been associated in different populations [6]. 
 
The present-day population structure of several pathogens, including Mycobacterium 
leprae and Mycobacterium tuberculosis, can be attributed to ancient human migrations 
[7, 8]. Such long-standing host–pathogen interactions could lead to adaptive genetic 
changes in both the host and pathogen populations [9]. Evidence of this can be seen 
from studies that have shown that M. tuberculosis lineages have adapted to speciﬁc 
human populations [9–11] and the selection of strains from a distinct sublineage by a 
human population in a deﬁned geographical setting [12]. In cosmopolitan settings, the 
association between particular M. tuberculosis complex (MTBC) lineages and their 
human hosts have remained even though some degree of intermingling of the different 
human populations has occurred [9–11]. 
 
Mycobacterium tuberculosis strains of the Beijing lineage are probably the most well 
characterized and are associated with increased virulence and transmission [13]. They 
are the most dominant strain lineage globally and have been reported in many Asian 
countries, and are emerging as the dominant strain in several other countries, including 
South Africa [14], Argentina, Cuba, Malawi, Vietnam, countries of the former Soviet 
Union, and parts of Western Europe [15]. Different M. tuberculosis strains induce 
different patterns of host immune response [16] as well as resulting in different disease 
phenotypes [17]. Beijing strains are also thought to be able to evade the protective effect 
of the BCG vaccine [18] and have evolved properties that allow them to cause disease 
more frequently than non-Beijing strains [19]. This could be due to their ability to 
modulate the host immunity toward a Th2 instead of a Th1 response or their inhibition of 
TNF-α release as demonstrated in activated THP-1 macrophages [20]. 
 
Within the Cape Town metropolis in South Africa, disease caused by the Beijing strains 
was found to be rising exponentially over a decade whereas disease caused by non-
Beijing strains has  remained  constant  [14]. Furthermore, Hanekom et al showed that 
the Beijing sublineage 7 strains were able to transmit and cause disease more 
frequently than strains from sublineages 2–6 in urban and rural populations of the 
Western Cape [12]. It appears that this is due to an evolutionary selection in local 
populations for this sublineage instead of a founder effect. 
 
In this study, we investigate the relationship between HLA class I molecules and disease 
by speciﬁc M. tuberculosis lineages, speciﬁcally those lineages occurring in the Western 
Cape, South Africa. We show that HLA class I variants are associated with several strains 
in our study cohort and that taking host and pathogen genetic factors into 








Materials and methods 
Ethics Statement 
Human blood and sputum samples were obtained with written informed consent for 
DNA extraction or culture and with approval from the Health Research Ethics 
Committee of Stellenbosch University, South Africa ( project registration numbers 
95/072 and 2003/022/N). 
 
Study Participants and Genotyping 
Participants for this study were recruited from suburbs in Cape Town, South Africa, 
where the incidence of tuberculosis was high (1005 per 100 000 in 2007) [21] and the 
prevalence of human immunodeﬁciency virus (HIV) was low [22]. These individuals 
belong to the South African Coloured (SAC) population, a highly admixed population 
[23]. Three hundred patients with bacteriologically conﬁrmed pulmonary tuberculosis 
were included in this study (mean age, 34.8 ± 12.6 years, 53% males). All participants 
were HIV negative and unrelated. 
 
The HLA class I genes were genotyped by direct sequencing. In brief, locus-speciﬁc 
primers ﬂanking exons 2 and 3 were used to amplify the HLA-A, -B and -C loci. The 
puriﬁed polymerase chain  reaction products were then sequenced using exon-speciﬁc 
primers and a BigDye Terminator version 3.1 cycle sequencing kit (Applied 
Biosystems) on the ABI-3130XL DNA analyzer. Sequence traces were analyzed using the 
Assign SBT 3.5.1 software (Conexio Genomics). HLA class I supertype classiﬁcation was 
done as described by Sidney et al for HLA-A and HLA-B [ 24 ]. HLA-C alleles were 
deﬁned based on their KIR2DL1 and KIR2DL2 binding [25] as previously done by 
Balamurugan et al [26 ]. Individuals who had alleles (4-digit) that could not be classiﬁed 
into a supertype were identiﬁed as “undeﬁned.” HLA class I allele frequency data for 
white and East Asian populations were obtained from the online Allele Frequency Net 
Database (AFND; www.allelefrequencies.net) [27] (see Supplementary Data for lists of 
countries). 
 
Bacterial Isolates and Genotyping 
Sputum samples were collected for culture at diagnosis from all new and retreatment 
tuberculosis patients who attended primary healthcare clinics and who were resident 
in an epidemiological ﬁeld site in Cape Town, South Africa, during the period January 
1993 to December 2004. 
 
Mycobacterium tuberculosis isolates were classiﬁed by culturing the sputum on 
mycobacteria growth indicator tube and/or Löwenstein-Jensen media, and isolates 
were classiﬁed by IS6110 restriction fragment length polymorphism genotyping and 
spoligotyping using internationally standardized protocols [14]. Strains were identiﬁed 
according to distinct IS6110 banding patterns using Gelcompar II  (Applied Maths) and 
were subsequently grouped into evolutionary clades that were classiﬁed based on their 
spoligotype signatures. Strains having <6 IS6110 bands (low-copy clade) comprise a 




Sublineages of the Beijing clade were identiﬁed as previously described [12]. 
Mycobacterium tuberculosis lineages were inferred as members of the East Asian or 
Euro-American MTBC lineages [9]. 
 
Statistical Analysis 
Logistic regression models were used to analyze the likelihood of tuberculosis cases having 
a speciﬁc strain, compared to having any other strain, because they enable us to adjust 
for other variables by including them in the models as covariates. All results were 
corrected for age and sex in this way. All P values, odds ratios (ORs), and their 
conﬁdence intervals (CIs) were derived from these models. Genetic association with the 
susceptibility to different strains was tested using each of the following as predictors in the 
models: genotypes, additive allelic effect, and additive haplotypes. The haplotypes were 
inferred, with their probabilities of being correct, and haplotypes were used as predictors 
in logistic regression models, with their probabilities as weights as previously described 
[28]. We tested for Hardy-Weinberg equilibrium (HWE) using the exact test [29]. 
 
A result or effect was described as signiﬁcant if P < .05. Bonferroni correction for 
multiple testing was not used, as this method is considered to be overly conservative 
when several genetic associations are tested in the same group of individuals  [ 30 ], 
resulting in the potential rejection of important ﬁndings. Bonferroni correction might 
also be inappropriate in a situation such as this where there is a priori evidence that the 
genes are associated with tuberculosis [31], whereas Bayesian methods for correction 
rely on knowledge of prior probability of involvement, which is currently unknown for 
most genetic variants  [ 32 ]. Current methods for multiple testing are only applicable if 
all tests are independent, which is not the case in this study, and therefore no 
appropriate method is available. All analyses were done in R (freely available from 
www.r-project.org) using functions from base R and R packages genetics and haplo.stats. 
 
Results 
Host Genotype and Multiplicity of Infections 
MTBC lineage, strain, and sublineage frequencies in this study cohort are listed in Table 
1. Most of the tuberculosis patients (90%) had only 1 episode of disease with infection 
caused by 1 strain, but 27 (9%) and 3 individuals (1%) had disease episodes caused by 2 
and 3 different strains, respectively. Of the 30 individuals with >1 disease episode, 19 
(63%) had 1 infection with the Beijing strain, and other episodes with another strain, 
whereas 37% of those with a non-Beijing strain had an additional episode with another 
strain. Figure 1 shows that of the 70 individuals with a Beijing strain, 19 (27%) had >1 
episode with different strains. Of the 19 individuals who had ≥2 infections of which 1 
was Beijing, Beijing was the ﬁrst infection in 6 cases, and a subsequent infection in 13 
cases. Having the HLA-B*27 allele was found to be signiﬁcantly associated (OR, 0.21 
[95% CI, .03–.68], P = .006) with having fewer strains. 
 
Relationship Between Host and Bacterial Genotype in Tuberculosis  Disease All genotype 




-B, and -C were signiﬁcantly associated with the genotype of the M. tuberculosis strain 
causing disease in the host. The Beijing strain was signiﬁcantly associated with each class 
of variation of the HLA class I genes, with the A*01, B*08, and C2 alleles increasing the 
odds of having disease with a Beijing strain (Table 2) with ORs ranging between 1.58 and 
2.32, while conversely, each B*27 and C1 allele lowered the odds of having disease with 
a Beijing strain (ORs, 0.35 and 0.60, respectively). Disease with a Beijing strain was also 
inﬂuenced by HLA-B and HLA-C genotypes, as well as 3 class I haplotypes (Table 3). 







Tuberculosis caused by LAM genotype strains was found to be signiﬁcantly associated 
with the A*03 allele (Table 2), where each additional allele increased the risk with an 




Two HLA-A genotypes were also associated with a LAM infection (Table 3). For the LCC 
strain (Table 2), each B*44 allele increased the risk of disease (OR, 2.07) whereas the 
presence of the B*07 allele lowered the chances of disease (OR, 0.49). The odds of 
disease with a Quebec strain (Table 2) was increased by the presence of the B*58 allele 
(OR, 2.69). 
 
As Beijing sublineage 7 is the most frequent sublineage in the Western Cape but not 
the rest of South Africa, we tested whether this could be attributed to the HLAs in 
the human host. We identiﬁed 2 signiﬁcant associations: where the A*30:02 allele 
occurred only in individuals with tuberculosis due to a Beijing sublineage 7 strain (P = 
.02) and is thus a potential risk factor, and with A*02:02 having a protective role 
against disease with Beijing sublineage 7 strain (OR, 0.04 [95% CI, .0–.51], P = .012). 
However, it should be noted that these Beijing sublineage 7 results are preliminary due 
to the small number of individuals (53 individuals with a sublineage 7 infection and 19 
individuals with a sublineage 2–6 infection) that could be included in this analysis. 
 
Relationship Between M. tuberculosis Phylogenetic Lineages and HLA Class I Allele 
Frequencies in Speciﬁc Geographical Populations Table 4 contains a summary of 
associations between MTBC lineages and HLA types in the SAC population, as well as 
the bacterial “footprint” of these MTBC lineages in various regions globally. 
Mycobacterium tuberculosis strains in our study group were separated into members of 










HLA class I allele frequencies of the ancestral populations were derived from AFND. In 
our SAC sample set there were 199 individuals with an Euro-American MTBC strain 
only, 57 with an East Asian MTBC strain only, 18 with strains from both MTBCs, and 
26 with neither. Several signiﬁcant associations were identiﬁed, with the following 
alleles associated with both MTBC member strains: A*23:01, B*14:01, B*14:02, and 
C*16:01. The A*23:01 and C*16:01 alleles were found to be less prevalent in those 
individuals with disease caused by a Euro-American MTBC strain, while increasing the 
risk of having disease caused by an East Asian MTBC strain. However, the HLA allele 
frequencies in the white and East Asian human populations do not correlate with this, as 
these alleles were found to be more prevalent in white populations than in East Asian 
populations. The opposite effect was seen for the B*14:01 and B*14:02 alleles, with all 
individuals carrying these alleles having a Euro-American MTBC strain. In this instance, 
the HLA population data for B*14:02 was in line with this ﬁnding as the allele occurs 





Individuals with disease caused by Euro-American MTBC strains were less likely to 
have the C*08:01 allele and more likely to have the A*74:01 and B*58:02 alleles. At the 
population level, alleles A*74:01 and B*58:02 occurred at the same frequency in both 
human populations, whereas allele C*08:01 was found at an extremely low frequency 
in the white population and at a very high frequency in the East Asian population, 
providing an inconsistent correlation between risk in the population of speciﬁc strains 
and frequency of HLA alleles. 
 
Statistically signiﬁcant associations with disease caused by East Asian MTBC strains 
were seen for the B*07:05 and B*35:01 alleles, with the former increasing the risk of 
having this strain and the latter reducing the chance (to zero in this study). These 
ﬁndings largely concur with the population data where the B*07:05 allele is found more 
frequently in East Asian populations than in white populations and the B*35:01 allele 
occurs more frequently in white populations than in East Asian populations. 
 
Discussion 
We report for the ﬁrst time a number of associations between human HLA class I types 
and speciﬁc M. tuberculosis strains. The role of the coevolution of host and pathogen in 
disease development has been difﬁcult to study in humans, with most of the proof of 
concept to date provided by studies of pathogen [9–12] and animal models [ 33 ]. We 
postulated a natural experiment in coevolution taking place in the Cape Town area, which 
has experienced a multiplicity of human visitors and their mycobacterial strains over the 
past 350 years. The resident population is extremely diverse [23], with inputs from 
Khoisan, Bantu, European, and Asian people and could therefore be assumed to have 
HLA types from all these ancestral populations. The M. tuberculosis strains present can 
be expected to have experienced intense competition and the incidence of tuberculosis is 
one of the highest in the world (1005 per 100 000 in 2007 [21]), thereby enabling us 
to investigate correlations between bacterial strain and HLA type in adequate numbers 
of patients. In this study we identiﬁed associations between HLA class I gene variants 
with certain strain genotypes, excluding Haarlem, Haarlem-like, and CAS1 strains, 
which occurred at very low frequencies within our study cohort. The strongest 
associations were identiﬁed for disease with Beijing genotype strains, which was found 
to be associated with several alleles, genotypes, and haplotypes of the HLA class I genes 
in the SAC population. Speciﬁc allelic associations were also identiﬁed for the LAM, 
LCC, and Quebec genotype strains. We showed that the Beijing genotype strains occurred 
more frequently in individuals with multiple disease episodes (P < .001) compared to 






The B*27 supertype reduced the odds of having multiple disease episodes, as well as 
having a Beijing strain. This super-type allele is found frequently in individuals who are 
able to control their HIV infections without any antiretroviral treatment and slow 
disease progression [ 34]. This is thought to be due to an increased CD8 T-cell 
response in individuals with this allele and induction of the apoptotic pathway through 
the increased presence of cytotoxic proteins [35]. The B*27 super-type has not 
previously been shown to be associated with susceptibility to tuberculosis [6 ]. 
 
Even though CD4+ T cells (HLA class II restricted) represent the predominant immune 
response mechanism against M. tuberculosis infection [36 ], there is growing evidence 
that suggests an important role for CD8+ T cells (HLA class I restricted) in protection 
against M. tuberculosis infection [37, 38]. Studies in animals and humans have shown 
that M. tuberculosis is capable of stimulating MHC class I restricted CD8+ T cells and 
the involvement of several different pathways for class I presentation of mycobacterial 
antigens via cross-presentation [39 ], where HLA class I recognition of mycobacterial 
antigens includes ESAT-6 (HLA-B*52), 19 kDa lipoprotein (HLA- A*02:01), and Ag85B 
(HLA-A*02:01) [37, 40, 41]. CD8+ T cells also have direct microbicidal activity and kill M. 
tuberculosis through the expression of granulysin and perforin [42 ]. HLA class I 
alleles have been associated with leprosy susceptibility [43], providing further support 
for the role of class I genes in immunity against mycobacterial infections. It is,  
however, possible that the strong LD between genes within the MHC complex  [ 44 ]   
could  mean  that  the  associations  found  here reﬂect the involvement of the class II 





To date, variants in the TLR2 [45], IRGM [46], and SLC11A1 [47] genes have shown a 
correlation between human and bacterial genotype. Variants in SLC11A1 and TLR2 were 
found to be associated with an increased risk of having tuberculosis with a Beijing strain 
in Asian populations, whereas in Ghana, the IRGM polymorphism was found to 
protect against disease caused by the Euro-American lineage. The phenotype of 
tuberculosis disease may be affected by the bacterial strain, as strains of the Euro-
American lineage appear to be less likely to cause extrapulmonary disease [45], whereas 
strains of the Beijing and S genotypes were associated with an increased risk of extra- 
thoracic disease [48]. In Vietnam, the relapse rate was signiﬁcantly increased in 
tuberculosis cases caused by Beijing strains, and this probably contributes to the 
successful spread of this strain family [49]. It is therefore evident that the outcome of 
exposure to M. tuberculosis depends on both the human and bacterial genotypes, and 
Alter et al [43] speculated that genetic heterogeneity in common infectious diseases 
could be at least partially explained by the pathogen strain differences, and patient 
strain types should therefore be incorporated into the analysis to overcome genetic 
heterogeneity. 
 
Both MTBC lineages and HLA allele frequencies are found in speciﬁc geographical 
settings; for example, lineages of an East Asian origin occur more frequently in human 
populations from the same region [9]. HLA allele frequencies are hugely dissimilar 
between different ethnic groups, with certain alleles completely absent in some 
populations [4 , 5]. We therefore investigated the frequencies of HLA class I alleles 
associated with the Euro-American and East Asian M. tuberculosis lineages, in their 
sympatric populations. We postulated that an allele more frequent in individuals with a 
Euro-American strain would also occur more frequently in white populations, whereas 
an allele that lowered the risk of having a Euro-American strain infection would occur 
at an extremely low frequency or be absent in white populations. The same rationale 
would apply to East Asian M. tuberculosis strains and human populations from East 
Asia. However, although results ﬁtting the postulate were found in several cases, there 
was no ﬁt in an equivalent number. This could be explained by the use of allele 
frequency averages across a number of populations listed in the databases. The 
A*23:01 allele for example, occurs between allele frequencies of 0.075 in the Beijing Han 
population (AFND), and 0.004 in the Shijiazhuang Tianjian Han, highlighting the 
enormous discrepancies between allele frequencies in populations of the same 
geographical region. Second, HLA genes are involved in several biological processes [1] 
and some could thus be under balancing selective pressures [3], which could have led to 
the discrepant ﬁndings. In spite of the limitations of this broad categorization of 
populations, we did ﬁnd several cases where the predominant MTBC lineage and the 
HLA class I allele frequency ﬁt the hypothesis of the coevolution of M. tuberculosis 
strains with the HLA class I genes. We now show  that speciﬁc strains are associated 
with HLA types of the host, thus providing a molecular genetic explanation for the 
previous observation by Gagneux et al, who correlated M. tuberculosis strain lineages 





The evolutionary forces on HLA have been extremely complex [3], including many 
bacterial and viral infections. We could thus be seeing the remaining association due to 
coevolution with M. tuberculosis and/or other diseases with similar clinical 
pathologies. Hershberg et al has postulated an “out-of-and-back-to-Africa” migration of 
MTBC that coincided with the out-of-Africa human migration pattern and the 
subsequent global human exploration quests [7]. Considering this hypothesis, the 
bottleneck events that accompanied the out-of-Africa migration, and the expansion of 
disease-causing variants within the last 5000 years [50], it is quite likely that coevolution 
between MTBC and their human hosts could have occurred. 
 
In summary, this study highlights the role of HLA class I molecules in infection with 
M. tuberculosis strains and emphasizes the importance of considering both host and 
pathogen genotype in understanding tuberculosis disease development and vaccine 
efﬁcacy. Host–pathogen coevolution has signiﬁcant biomedical and epidemiological 
implications and by identifying the genes involved in this interaction, the adaptation 
mechanisms of host and pathogen can be understood, as well as the limitations they 
impose upon each other. It is also likely that the complexity of HLA types within any 
given population, and the possible balancing effects of increased susceptibility to 
tuberculosis vs other pathogens or conditions, will prevent any simple correlations 
being seen between the predominant HLA type in a population and the strain of M. 
tuberculosis in that area. 
 
Supplementary Data 
Supplementary materials are available at The Journal of Infectious Diseases online 
(http://jid.oxfordjournals.org/). Supplementary materials consist of data provided by 
the author that are published to beneﬁt the reader. The posted materials are not 
copyedited. The contents of all supplementary data are the sole responsibility of the 
authors. Questions or messages regarding errors should be addressed to the author. 
 
Notes 
Acknowledgments. We thank all study participants for their cooperation. 
Financial support. This work was supported by the Wellcome Trust (053844/Z/98/Z 
to P. D. vH. and E. G. H.); Frederick National Laboratory for Cancer Research (contract 
number HHSN261200800001E); the Intramural Research Program of the NIH, 
Frederick National Lab, Center for Cancer Research; the Harry Crossley Foundation; 
the National Research Foundation (DAAD-NRF); and the Columbia University-
Southern African Fogarty AIDS International Training and Research Program through 
the Fogarty International Center, National Institutes of Health (grant number 2 D43 
TW000231 16 to M. S.). 
Potential conﬂicts of interest.   All authors: No reported conﬂicts. 
All authors have submitted the ICMJE Form for Disclosure of Potential Conﬂicts of 
Interest. Conﬂicts that the editors consider relevant to the content of the manuscript 






1.  Kostyu DD, Hannick LI, Traweek JL, Ghanayem M, Heilpern D,   Dawson DV. 
HLA class I polymorphism: structure and function and  still questions. Hum 
Immunol 1997; 57:1–18. 
2.  Cao K, Hollenbach J, Shi X, Shi W, Chopek M, Fernández-Viña MA.   Analysis of 
the frequencies of HLA-A, B, and C alleles and haplotypes   in the ﬁve major ethnic 
groups of the United States reveals high levels   of diversity in these loci and 
contrasting distribution patterns in these  populations. Hum Immunol 2001; 
62:1009–30. 
3. Spurgin LG, Richardson DS. How pathogens drive genetic diversity: MHC, 
mechanisms and misunderstandings. Proc Biol Sci 2010; 277:979–88. 
4.  Lombard Z, Brune AE, Hoal EG, et al. HLA class II disease associations in southern 
Africa. Tissue Antigens 2006; 67:97–110. 
5. Abi-Rached L, Jobin MJ, Kulkarni S, et al. The shaping of modern human 
immune systems by multiregional admixture with archaic humans. Science 2011; 
334:89–94. 
6.  Kettaneh A, Seng L, Tiev KP, Tolédano C, Fabre B, Cabane J. Human  leukocyte 
antigens and susceptibility to tuberculosis: a meta-analysis of   case-control studies. 
Int J Tuberc Lung Dis 2006; 10:717–25. 
7. Hershberg R, Lipatov M, Small PM, et al. High functional diversity in  
Mycobacterium tuberculosis driven by genetic drift and human demography. PLoS 
Biol 2008; 6:e311. 
8.  Monot M, Honoré N, Garnier T, et al. On the origin of leprosy. Science 2005; 
308:1040–2. 
9. Gagneux S, Deriemer K, Van T, et al. Variable host-pathogen compatibility in 
Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 2006; 103:2869–73. 
10. Hirsh AE, Tsolaki AG, DeRiemer K, Feldman MW, Small PM. Stable association 
between strains of Mycobacterium tuberculosis and their human host 
populations. Proc Natl Acad Sci U S A 2004; 101:4871–6. 
11. Reed MB, Pichler VK, McIntosh F, et al. Major Mycobacterium tuberculosis lineages 
associate with patient country of origin. J Clin Microbiol 2009; 47:1119–28. 
12. Hanekom M, van der Spuy GD, Streicher E, et al. A recently evolved sublineage of 
the Mycobacterium tuberculosis Beijing strain family is associated with an increased 
ability to spread and cause disease. J Clin Microbiol 2007; 45:1483–90. 
13. Hanekom M, Gey van Pittius NC, McEvoy C, Victor TC, Van Helden  PDWarren 
RM. Mycobacterium tuberculosis Beijing genotype: a template for success. 
Tuberculosis (Edinb) 2011; 91:510–23. 
14. Van der Spuy GD, Kremer K, Ndabambi SL, et al. Changing Mycobacterium 
tuberculosis population highlights clade-speciﬁc pathogenic characteristics. 
Tuberculosis (Edinb) 2009; 89:120–5. 
15.  European Concerted Action on New Generation Genetic Markers and  Techniques 
for the Epidemiology and Control of Tuberculosis. Beijing/   W genotype 





16. Manca C, Reed MB, Freeman S, et al. Differential monocyte activation underlies 
strain-speciﬁc Mycobacterium tuberculosis pathogenesis. Infect Immun 2004; 
72:5511–4. 
17. Lopez B, Aguilar D, Orozco H, et al. A marked difference in pathogenesis and 
immune response induced by different Mycobacterium tuberculosis genotypes. Clin 
Exp Immunol 2003; 133:30–7. 
18. Kremer K, van-der-Werf MJ, Au BKY, et al. Vaccine-induced immunity 
circumvented by typical Mycobacterium tuberculosis Beijing strains. Emerg Infect Dis 
2009; 15:335–9. 
19. Sreevatsan S, Pan X, Stockbauer KE, et al. Restricted structural gene 
polymorphism in the Mycobacterium tuberculosis complex indicates 
evolutionarily recent global dissemination. Proc Natl Acad Sci U S A 1997; 
94:9869–74. 
20. Theus S, Eisenach K, Fomukong N, Silver RF, Cave MD. Beijing family  
Mycobacterium tuberculosis strains differ in their intracellular growth in THP-1 
macrophages. Int J Tuberc Lung Dis 2007; 11:1087–93. 
21. Health Systems Trust. Incidence of TB in the provinces of South Africa,  2009. 
Available at: http://www.hst.org.za/healthstats/16/data. Accessed 17 May 2011. 
22. Kritzinger FE, den BS, Verver S, et al. No decrease in annual risk of tuberculosis 
infection in endemic area in Cape Town, South Africa. Trop Med Int Health 2009; 
14:136–42. 
23. De Wit E, Delport W, Rugamika CE, et al. Genome-wide analysis of the structure of 
the South African Coloured population in the Western Cape. Hum Genet 2010; 
128:145–53. 
24.  Sidney J, Peters B, Frahm N, Brander C, Sette A. HLA class I super- types: a revised 
and updated classiﬁcation. BMC Immunol 2008; 9:1. 
25. Colonna M, Borsellino G, Falco M, Ferrara GB, Strominger JL. HLA-C is the 
inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-
speciﬁc natural killer cells. Proc Natl Acad Sci U S A 1993; 90:12000–4. 
26.  Balamurugan A, Sharma SK, Mehra NK. Human leukocyte antigen  class I 
supertypes inﬂuence susceptibility and severity of tuberculosis. J Infect Dis 2004; 
189:805–11. 
27. Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR. Allele fre quency net: a 
database and online repository for immune gene frequencies in worldwide 
populations. Nucleic Acids Res 2011; 39:D913–9. 
28. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score  tests for 
association between traits and haplotypes when linkage phase is ambiguous. Am J 
Hum Genet 2002; 70:425–34. 
29. Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy-Weinberg 
equilibrium. Am J Hum Genet 2005; 76:887–93. 
30. Nyholt DR. A simple correction for multiple testing for single-nucleotide 
polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 
2004; 74:765–9. 




32.  Campbell H, Rudan I. Interpretation of genetic association studies in  complex 
disease. Pharmacogenomics J 2002; 2:349–60. 
33. Di Pietrantonio T, Correa JA, Orlova M, Behr MA, Schurr E. Joint  effects of 
host genetic background and mycobacterial pathogen on susceptibility to infection. 
Infect Immun 2011; 79:2372–8. 
34. Migueles SA, Connors M. Long-term nonprogressive disease among  untreated 
HIV-infected individuals: clinical implications of understanding immune control 
of HIV. JAMA 2010; 304:194–201. 
35. Migueles SA, Weeks KA, Nou E, et al. Defective human immunodeﬁciency virus-
speciﬁc CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not 
restored by antiretroviral therapy. J Virol 2009; 83:11876–89. 
36. Kaufmann SH. How can immunology contribute to the control of tuberculosis? 
Nat Rev Immunol 2001; 1:20–30. 
37. Geluk A, van Meijgaarden KE, Franken KL, et al. Identiﬁcation of major 
epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-
A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans. J Immunol 
1950 2000; 165:6463–71. 
38. Lazarevic V, Flynn J. CD8+ T cells in tuberculosis. Am J Respir Crit Care Med 
2002; 166:1116–21. 
39. Sigal LJ, Crotty S, Andino R, Rock KL. Cytotoxic T-cell immunity to  virus-
infected non-haematopoietic cells requires presentation of exogenous antigen. 
Nature 1999; 398:77–80. 
40. Lalvani A, Brookes R, Wilkinson RJ, et al. Human cytolytic and interferon gamma-
secreting CD8+ T lymphocytes speciﬁc for Mycobacterium tuberculosis. Proc Natl 
Acad Sci U S A 1998; 95:270–5. 
41.  Mohagheghpour N, Gammon D, Kawamura LM, van Vollenhoven A, Benike CJ, 
Engleman EG. CTL response to Mycobacterium tuberculosis:  identiﬁcation of an 
immunogenic epitope in the 19-kDa lipoprotein. J Immunol 1950 1998; 161:2400–
6. 
42. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001; 19:93–
129. 
43. Alter A, Huong NT, Singh M, et al. Human leukocyte antigen class I region 
single-nucleotide polymorphisms are associated with leprosy susceptibility in 
Vietnam and India. J Infect Dis 2011; 203:1274–81. 
44.  Traherne JA. Human MHC architecture and evolution: implications for disease 
association studies. Int J Immunogenet 2008; 35:179–92. 
45. Caws M, Thwaites G, Dunstan S, et al. The inﬂuence of host and bacterial genotype 
on the development of disseminated disease with Mycobacterium tuberculosis. 
PLoS Pathog 2008; 4:e1000034. 
46. Intemann CD, Thye T, Niemann S, et al. Autophagy gene variant IRGM -261 T 
contributes to protection from tuberculosis caused by  Mycobacterium 
tuberculosis but not by M. africanum strains. PLoS Pathog 2009; 5:e1000577. 
47. Van Crevel R, Parwati I, Sahiratmadja E, et al. Infection with Mycobac- terium 




SLC11A1/NRAMP1 in Indonesian patients with tuberculosis. J Infect Dis 2009; 
200:1671–4. 
48. Hesseling AC, Marais BJ, Kirchner HL, et al. Mycobacterial genotype is associated 
with disease phenotype in children. Int J Tuberc Lung Dis 2010; 14:1252–8. 
49. Huyen MNT, Buu TN, Tiemersma E, et al. Tuberculosis relapse in Vietnam is 
signiﬁcantly associated with Mycobacterium tuberculosis Beijing genotype 
infections. J Infect Dis 2013; 207:1516–24. 
50. Fu W, O’Connor TD, Jun G, et al. Analysis of 6,515 exomes reveals the recent 
origin of most human protein-coding variants. Nature 2013; 493:216–20. HLA 
 
 
http://repository.uwc.ac.za
